輸入代號或公司名稱後按 Enter
6703

軒郁

+0.50 (+0.50%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
101.0015成交張數9.79本益比2.56股價淨值比1.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20253,287年增 -8.3%
毛利率202562.6%最新一期
營業利益率202512.3%最新一期
每股盈餘20259.90年增 -2.6%
會計項目走勢202020212022202320242025
銷貨收入101.7%101.9%101.1%101.0%101.4%101.8%
銷貨退回0.5%1.0%0.4%0.5%0.7%0.9%
銷貨折讓1.3%0.9%0.6%0.5%0.7%0.9%
銷貨收入淨額100.0%100.0%100.0%100.0%100.0%100.0%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%
銷貨成本31.3%32.0%34.7%34.2%38.1%37.4%
營業成本合計31.3%32.0%34.7%34.2%38.1%37.4%
營業毛利(毛損)68.7%68.0%65.3%65.8%61.9%62.6%
營業毛利(毛損)淨額68.7%68.0%65.3%65.8%61.9%62.6%
推銷費用51.5%47.7%46.0%43.7%46.6%44.3%
管理費用4.1%4.9%4.7%3.7%4.0%4.5%
研究發展費用1.3%1.6%1.6%1.5%1.3%1.5%
預期信用減損損失(利益)0.0%0.0%-0.0%-0.0%
營業費用合計56.8%54.2%52.3%49.0%51.9%50.3%
營業利益(損失)11.9%13.8%13.0%16.8%10.0%12.3%
利息收入0.1%0.0%0.1%0.2%0.2%0.2%
其他收入0.1%0.0%0.1%0.0%0.1%0.1%
其他利益及損失淨額-0.6%-0.6%0.3%0.1%0.2%0.1%
財務成本淨額0.0%0.0%0.0%0.2%0.3%0.4%
營業外收入及支出合計-0.5%-0.6%0.4%0.1%0.1%-0.1%
稅前淨利(淨損)11.4%13.3%13.4%17.0%10.1%12.2%
所得稅費用(利益)合計2.3%2.8%2.8%3.5%2.1%2.5%
繼續營業單位本期淨利(淨損)9.1%10.5%10.7%13.5%8.0%9.7%
本期淨利(淨損)9.1%10.5%10.7%13.5%8.0%9.7%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益0.1%5.1%-1.1%0.5%-0.8%0.1%
不重分類至損益之項目:0.1%5.1%-1.1%0.5%-0.8%0.1%
國外營運機構財務報表換算之兌換差額0.0%-0.0%0.0%-0.0%0.0%-0.0%
與可能重分類之項目相關之所得稅-0.0%-0.0%0.0%-0.0%0.0%-0.0%
後續可能重分類至損益之項目:0.1%-0.0%0.0%-0.0%0.0%-0.0%
其他綜合損益(淨額)0.1%5.1%-1.1%0.5%-0.8%0.1%
本期綜合損益總額9.2%15.6%9.5%13.9%7.2%9.7%
母公司業主(淨利∕損)9.1%10.5%10.7%13.6%8.4%9.9%
非控制權益(淨利∕損)-0.0%-0.0%0.0%-0.1%-0.3%-0.2%
母公司業主(綜合損益)9.2%15.6%9.5%14.0%7.6%9.9%
非控制權益(綜合損益)-0.0%-0.0%0.0%-0.1%-0.3%-0.2%
基本每股盈餘0.5%0.5%0.5%0.5%0.3%0.3%
稀釋每股盈餘0.5%0.5%0.4%0.5%0.3%0.3%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。